Emicizumab and thrombosis: The story so far
J Thromb Haemost
.
2019 Aug;17(8):1269-1272.
doi: 10.1111/jth.14556.
Authors
Michael Makris
1
2
,
Alfonso Iorio
3
,
Peter J Lenting
4
Affiliations
1
Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
2
Sheffield Haemophilia and Thrombosis Centre, Royal Hallamshire Hospital, Sheffield, UK.
3
Department of Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
4
INSERM, U1176, Universite Paris-Sud, Le Kremlin-Bicetre, France.
PMID:
31368220
DOI:
10.1111/jth.14556
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Bispecific*
Antibodies, Monoclonal, Humanized
Humans
Thrombosis*
Substances
Antibodies, Bispecific
Antibodies, Monoclonal, Humanized
emicizumab